| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.8 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |